Evidence map›Paper›PMID 32801413›Full record

ReviewIranian journal of medical sciences2020

A Narrative Review of COVID-19: The New Pandemic Disease.

Kiana Shirani, Erfan Sheikhbahaei, Zahra Torkpour, Mazyar Ghadiri Nejad, Bahareh Kamyab Moghadas, Matina Ghasemi, Hossein Akbari Aghdam, Athena Ehsani, Saeed Saber-Samandari, Amirsalar Khandan

Open access · greenAbstract readReview
In one paragraph

Review in Iranian journal of medical sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Clinical cardiovascular emergencies and the cellular basis of COVID-19 vaccination: from dream to reality?International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2022
    Review
  5. Article
  6. Article
  7. Article
  8. Quantum dots against SARS-CoV-2: diagnostic and therapeutic potentials.Journal of chemical technology and biotechnology (Oxford, Oxfordshire : 1986) · 2022
    Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Association of systemic complications with mortality in coronavirus disease of 2019: A cohort study on intensive care unit patients.Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2022
    Article
  14. Article
  15. Chest Radiological Findings and Clinical Characteristics of Laboratory-Confirmed COVID-19 Patients from Saudi Arabia.Medical science monitor : international medical journal of experimental and clinical research · 2021
    Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Clinical manifestation, laboratory and radiology finding, treatment and outcomes of COVID-19: A systematic review and meta-analysis.Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Kiana ShiraniInfectious Diseases and Tropical Medicine Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Erfan SheikhbahaeiStudent Research Committee, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Zahra TorkpourStudent Research Committee, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Mazyar Ghadiri NejadIndustrial Engineering Department, Girne American University, Kyrenia, TRNC, Turkey.
Bahareh Kamyab MoghadasDepartment of Chemical Engineering, Shiraz Branch, Islamic Azad University, Shiraz, Iran.
Matina GhasemiFaculty of Business and Economics, Business Department, Girne American University, Kyrenia, TRNC, Turkey.
Hossein Akbari AghdamDepartment of Orthopedic Surgery, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Athena EhsaniDepartment of Biomedical Engineering, Science and Research Branch, Islamic Azad University, Tehran, Iran.
Saeed Saber-SamandariNew Technologies Research Center, Amirkabir University of Technology, Tehran, Iran.
Amirsalar KhandanDepartment of Electrical Engineering, Isfahan (Khorasgan) Branch, Islamic Azad University, Isfahan, Iran.
Isfahan University of Medical Sciences · IRAmirkabir University of Technology · IRIslamic Azad University, Isfahan · IRIslamic Azad University of Shiraz · IRIslamic Azad University, Science and Research Branch · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nearly every 100 years, humans collectively face a pandemic crisis. After the Spanish flu, now the world is in the grip of coronavirus disease 2019 (COVID-19). First detected in 2019 in the Chinese city of Wuhan, COVID-19 causes severe acute respiratory distress syndrome. Despite the initial evidence indicating a zoonotic origin, the contagion is now known to primarily spread from person to person through respiratory droplets. The precautionary measures recommended by the scientific community to halt the fast transmission of the disease failed to prevent this contagious disease from becoming a pandemic for a whole host of reasons. After an incubation period of about two days to two weeks, a spectrum of clinical manifestations can be seen in individuals afflicted by COVID-19: from an asymptomatic condition that can spread the virus in the environment, to a mild/moderate disease with cold/flu-like symptoms, to deteriorated conditions that need hospitalization and intensive care unit management, and then a fatal respiratory distress syndrome that becomes refractory to oxygenation. Several diagnostic modalities have been advocated and evaluated; however, in some cases, diagnosis is made on the clinical picture in order not to lose time. A consensus on what constitutes special treatment for COVID-19 has yet to emerge. Alongside conservative and supportive care, some potential drugs have been recommended and a considerable number of investigations are ongoing in this regard.

Indexed as

CoronavirusCOVID-19EpidemiologyPandemicsSARS virus

Identifiers

PMID32801413
PMCPMC7395956
OpenAlexW3039092892

What OpenQuestion holds

Textmetadata
LicenceCC BY-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.